Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.

Harper, C M

Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome. [electronic resource] - Annals of the New York Academy of Sciences May 1998 - 203-6 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0077-8923

10.1111/j.1749-6632.1998.tb10929.x doi


Adolescent
Adult
Aged
Child
Humans
Middle Aged
Myasthenia Gravis--drug therapy
Point Mutation
Quinidine--adverse effects
Receptors, Cholinergic--genetics
Syndrome